---
title: "TIBET PHARMA (600211.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600211.SH/norm.md"
symbol: "600211.SH"
name: "TIBET PHARMA"
parent: "https://longbridge.com/en/quote/600211.SH.md"
datetime: "2026-03-05T05:14:18.739Z"
locales:
  - [en](https://longbridge.com/en/quote/600211.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600211.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600211.SH/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/600211.SH/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/600211.SH/norm.md)


# TIBET PHARMA (600211.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.4797 | 0.9196 | 0.8400 | 0.8001 | 0.5274 |
| ROE | 16.02% | 28.86% | 26.86% | 27.50% | 18.19% |
| Revenue | 438.57M | 938.60M | 712.11M | 631.27M | 560.75M |
| Net income | 154.45M | 298.04M | 269.28M | 259.42M | 168.73M |
| Operating income | 178.66M | 315.24M | 248.89M | 61.39M | 176.18M |
| Gross margin | 90.61% | 94.42% | 94.76% | 91.80% | 92.73% |
| Net margin | 35.22% | 31.75% | 37.81% | 41.10% | 30.09% |
| Profit quality | 158.31% | 108.55% | 80.34% | 24.80% | 115.49% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 5.82B | 5.66B | 5.22B | 4.75B | 4.67B |
| Leverage | 1.48 | 1.35 | 1.26 | 1.20 | 1.27 |
| BVPS | 11.02 | 12.91 | 12.72 | 12.16 | 11.26 |
| Turnover | 0.5188 | 0.5169 | 0.5459 | 0.6014 | 0.6264 |
| Cash & STI | 3.27B | 3.03B | 3.13B | 2.62B | 2.59B |
| Inv & Rec | 174.65M | 149.26M | 148.80M | 134.19M | 137.48M |
| LT assets | 662.68M | 652.43M | 661.60M | 669.85M | 574.86M |
| Net debt | -2.30B | -2.33B | -2.61B | -2.35B | -2.06B |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 112.85M | 290.41M | 309.81M | 247.53M | 152.55M |
| Investing CF | -202.27M | -99.71M | -298.59M | 183.41M | 389.07M |
| Financing CF | -64.42M | -55.75M | 158.44M | -116.71M | -677.62M |
| Free CF | 54.71M | 181.55M | 199.32M | 94.46M | -3.83M |
| OCF coverage | 39.39% | 70.59% | 342.98% | 103.64% | 22.36% |
| Repaid & issued | 220.47M | 352.29M | 243.97M | 99.45M | 1.01M |
| CapEx | -1.63M | -4.54M | -4.80M | -23.72M | -3.52M |

## Distribution Plan

**Dividend Yield**: 3.88

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.881CNY | 2025-08-29 | 2025-09-01 | 2025-09-01 |
| Cash Dividend: 
0.728CNY | 2025-04-21 | 2025-04-22 | 2025-04-22 |
| Cash Dividend: 
0.262CNY | 2025-01-20 | 2025-01-21 | 2025-01-21 |